Skip to main content
OpenTrials
Completed

NCT Number: NCT03010813

A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery

This is a prospective, single center, multispecialty study that aimed to evaluate the clinical feasibility and safety of single port surgery and NOTES (mainly transanal and transoral surgery) using a novel single port robotic system.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Background: Single port surgery and natural orifice transluminal endoscopic surgery (NOTES) are emerging minimally invasive surgery techniques which can further reduce patient trauma and enhance recovery. However, the wider adoption of these techniques is hampered by the limitation of instrumentation and technical difficulties. Robotic assistance may improve surgical capabilities during single port surgery and NOTES by providing augmented motion precision and manipulation dexterity.

Objectives: To evaluate the clinical feasibility and safety of single port surgery and NOTES (mainly transanal and transoral surgery) using a novel single port robotic system.

Design: Prospective, single center, multispecialty study consistent with a stage 1 (Innovation) study described in the Innovation, Development, Exploration, Assessment, Long-term Study (IDEAL) framework.

Subjects: Sixty consecutive patients with various benign/malignant pathologies indicated for single port colorectal/urologic surgery or transanal/transoral surgery who fulfilled all the inclusion and exclusion criteria will be recruited.

Intervention: Single port surgery and transanal/transoral surgery will be performed using the novel single port robotic system.

Study Endpoints: Primary: conversion rate and perioperative complications. Secondary: operative time, blood loss, pain scores, analgesic requirement, and length of stay.

Hypothesis: The prospective study will provide important information on the feasibility, safety, and effectiveness of the novel single port robotic system in performing single port surgery and NOTES in various surgical specialties. A positive study will provide supporting evidence for continuing development of this new technology.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

GENERAL INCLUSION CRITERIA FOR ALL PROCEDURES

  • Body mass index <35 kg/m2
  • Suitable for minimally invasive surgery
  • Willingness to participate as demonstrated by giving informed consent

GENERAL EXCLUSION CRITERIA FOR ALL PROCEDURES

  • Contraindication to general anesthesia
  • Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
  • Untreated active infection
  • Noncorrectable coagulopathy
  • Presence of another malignancy or distant metastasis
  • Emergency surgery
  • Vulnerable population (e.g. mentally disabled, pregnancy)

Treatment and study plan

Robotic single port surgery and NOTES

Procedure

Robotic single port colorectal surgery; Robotic transanal surgery; Robotic single port urologic surgery; Transoral robotic surgery

Primary outcomes

  1. Conversion rate

    Time frame: Up to 1 month

    An emergent change in the treatment plan to conventional minimally invasive (laparoscopic/endoscopic) surgery (i.e. the use of more than one additional port), multiport robotic surgery, or to open surgery

  2. Perioperative complications

    Time frame: Up to 1 month

    Complications including intraoperative complications and all complications occurring during the hospital stay or within 30 days after discharge will be graded according to the Clavien-Dindo classification

Secondary outcomes

  1. Operative time

    Time frame: Intraoperative

  2. Estimated blood loss

    Time frame: Up to 1 month

  3. Pain scores on a visual analog scale

    Time frame: Up to 1 month

  4. Analgesic requirement

    Time frame: Up to 1 month

  5. Length of hospital stay

    Time frame: Up to 1 month

  6. Completeness of resection

    Time frame: Up to 1 month

    Pathologic examination of the resected specimen for completeness of resection

  7. Resection margins

    Time frame: Up to 1 month

    Pathologic examination of the resected specimen for resection margins positivity

  8. Number of lymph nodes harvested

    Time frame: Up to 1 month

    Pathologic examination of the resected specimen (malignant cases)

  9. Anal continence after transanal surgery

    Time frame: Up to 1 year

    After transanal surgery; using the Cleveland Clinic Incontinence Score (Wexner's Score)

  10. Fecal incontinence quality of life after transanal surgery

    Time frame: Up to 1 year

    After transanal surgery; using the validated Chinese version of the Fecal Incontinence Quality of Life Scale (FIQL)

  11. Urinary continence after radical prostatectomy

    Time frame: Up to 1 year

    After radical prostatectomy; assessed by recording the number of pads used per day

  12. Male sexual function after radical prostatectomy

    Time frame: Up to 1 year

    After radical prostatectomy; using the abridged version of the International Index of Erectile Dysfunction - erectile function domain score (IIEF-EF)

  13. Renal function after nephrectomy

    Time frame: Up to 1 year

    After nephrectomy; using renal function blood tests for urea and creatinine

  14. Swallowing function after transoral robotic surgery (TORS)

    Time frame: Up to 1 year

    After TORS; using the MD Anderson Dysphagia Inventory

  15. Voice function after TORS

    Time frame: Up to 1 year

    After TORS; using the Voice Handicap Index (VHI) 30

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Official study title

A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery: A Prospective, Single Center, Multispecialty Study

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jan 5, 2017
Registry last updated
Feb 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.